Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers

MLA

Jihan K. Zaki, et al. “Diagnostic Model Development for Schizophrenia Based on Peripheral Blood Mononuclear Cell Subtype-Specific Expression of Metabolic Markers.” Translational Psychiatry, vol. 12, no. 1, Oct. 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1038/s41398-022-02229-w.

APA

Jihan K. Zaki, Santiago G. Lago, Nitin Rustogi, Shiral S. Gangadin, Jiri Benacek, Geertje F. van Rees, Frieder Haenisch, Jantine A. Broek, Paula Suarez-Pinilla, Tillmann Ruland, Bonnie Auyeung, Olya Mikova, Nikolett Kabacs, Volker Arolt, Simon Baron-Cohen, Benedicto Crespo-Facorro, Hemmo A. Drexhage, Lot D. de Witte, René S. Kahn, … Jakub Tomasik. (2022). Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers. Translational Psychiatry, 12(1), 1–10. https://doi.org/10.1038/s41398-022-02229-w

Chicago

Jihan K. Zaki, Santiago G. Lago, Nitin Rustogi, Shiral S. Gangadin, Jiri Benacek, Geertje F. van Rees, Frieder Haenisch, et al. 2022. “Diagnostic Model Development for Schizophrenia Based on Peripheral Blood Mononuclear Cell Subtype-Specific Expression of Metabolic Markers.” Translational Psychiatry 12 (1): 1–10. doi:10.1038/s41398-022-02229-w.